EIKN
Eikon Therapeutics, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$10.86
−0.96%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-69.5%
Return on equity
-41.6%
Return on assets
-47.2%
Return on invested capital
0.00x
Asset turnover
-$188.5M
Cash from operations
$9.81
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026